Talassemiat - Related Resources

Cochrane reviews

• There is no evidence to suggest that either oral deferiprone or subcutaneous infusion of desferrioxamine (DFO) is more clinically efficacious to prevent end organ damage in transfusion-dependent thalassaemia Oral Deferiprone for Iron Chelation in People with Thalassaemia.
• Iron chelation with desferrioxamine appears to be beneficial in people with transfusion-dependent thalassaemia but the optimal schedule remains uncertain Desferrioxamine Mesylate for Iron Overload in Transfusion-Dependent Thalassaemia.